Elevance Health, Inc. (ELV) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — ELV

Balance Sheet

(in billions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	10.23	9.66	8.71	8.56	7.50	7.87	6.50	6.23	10.92	9.99	10.14	8.87	6.46	6.16	5.49	5.26	9.33
Total Current Assets	67.18	67.03	63.78	63.32	61.12	62.85	62.27	60.95	61.19	59.74	59.82	55.60	53.66	53.90	51.90	50.24	54.50
Total Assets	126.44	125.83	122.75	121.94	119.72	116.53	112.99	111.89	110.48	109.17	109.04	103.03	100.88	100.49	98.06	96.10	95.68
Total Current Liabilities	44.25	45.31	40.88	43.83	42.70	42.03	41.81	44.33	43.34	41.57	41.89	41.29	39.31	39.73	35.16	33.79	34.75
Long-term Debt	31.04	31.12	31.17	28.18	28.11	24.69	24.56	21.98	23.85	24.86	25.20	21.26	21.17	19.88	21.76	22.22	22.53
Total Liabilities	81.42	81.79	78.67	78.09	77.10	72.65	70.69	71.18	71.94	70.86	71.58	66.98	65.01	64.46	62.25	61.05	61.77
Retained Earnings	36.67	35.80	35.59	35.55	34.55	35.16	34.58	33.09	32.10	31.61	30.71	29.60	28.83	28.06	26.70	25.87	24.79
Total Stockholder Equity	44.88	43.90	43.95	43.72	42.50	43.78	42.19	40.61	38.42	38.21	37.36	35.99	35.81	35.98	35.74	34.97	33.85

Income Statement

(in billions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Net Premiums Earned	41.28	41.02	40.69	41.79	41.27	40.89	36.24	36.81	35.42	35.70	35.14	35.26	36.59	35.87	33.65	33.72	33.08	32.78	30.77	30.40
Net Investment Income	0.70	0.77	0.49	0.63	0.49	0.59	0.53	0.55	0.51	0.47	0.53	0.49	0.42	0.39	0.37	0.37	0.38	0.36	0.35	0.34
Total Revenue	50.47	50.18	49.75	50.71	49.78	48.89	45.44	45.11	43.89	42.58	42.65	42.85	43.67	42.17	39.93	39.94	38.63	38.10	36.58	35.82
Benefits & Claims	37.02	35.62	38.07	38.14	36.71	35.31	33.50	32.95	30.57	30.55	31.33	30.61	31.60	--	30.09	29.40	28.78	28.22	27.54	26.65
Total Benefits & Expenses	48.54	47.88	49.53	49.31	47.48	46.09	44.84	43.73	40.90	39.64	41.65	41.20	41.23	39.55	38.78	37.79	36.49	35.77	35.18	33.83
Operating Income	1.76	2.09	0.31	1.30	2.42	3.17	0.67	1.41	2.77	3.02	1.28	1.76	2.63	2.83	1.37	2.27	2.37	2.45	1.19	2.06
Tax Provision	0.48	0.54	(0.33)	0.22	0.55	0.61	0.19	0.37	0.69	0.69	0.17	0.35	0.59	0.62	0.19	0.53	0.49	0.53	0.28	0.49
Net Income	1.46	1.76	0.55	1.19	1.74	2.18	0.42	1.02	2.30	2.25	0.86	1.29	1.85	1.99	0.95	1.62	1.65	1.81	1.14	1.51
Diluted EPS	6.71	8.00	2.56	5.32	7.72	9.61	1.88	4.36	9.85	9.59	3.68	5.45	7.79	8.30	3.95	6.68	6.79	7.39	4.64	6.13

Cash Flow Statement

(in billions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	1.91	4.33	0.08	1.14	2.05	1.02	0.71	2.68	0.45	1.98	(2.97)	2.61	1.95	6.47	(1.52)	4.92	2.45	2.54	1.67	2.50
Capital Expenditures	0.29	0.24	0.29	0.36	0.27	0.20	0.32	0.33	0.32	0.28	0.33	0.32	0.35	0.30	0.30	0.31	0.30	0.25	0.34	0.26
Free Cash Flow*	1.63	4.10	(0.21)	0.78	1.79	0.82	0.38	2.35	0.12	1.70	(3.30)	2.29	1.60	6.17	(1.82)	4.62	2.16	2.29	1.33	2.25
Investing Cash Flow	0.16	(1.64)	0.46	(1.22)	(0.69)	0.10	(1.64)	(0.40)	(0.82)	(2.31)	(1.03)	(0.69)	(0.67)	(3.18)	0.29	(1.25)	(2.02)	(1.58)	(0.97)	(1.44)
Financing Cash Flow	(1.49)	(2.51)	0.24	0.24	(0.31)	(1.91)	1.41	(0.91)	0.67	0.03	(0.39)	(0.99)	(1.43)	(0.53)	(0.26)	(1.25)	(0.13)	0.32	(1.31)	(0.83)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q4 2022	Q1 2022	Q4 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Dividends Per Share	1.72	1.72	1.71	1.71	1.71	1.63	1.63	1.63	1.48	1.48	1.48	1.28	1.28	1.13	1.13	1.13	0.95	0.95	0.95	0.95